| Zugriffe | |
|---|---|
| A Randomized, Double‐Blind Study Comparing Pharmacokinetics and Pharmacodynamics of Proposed Biosimilar ABP 798 With Rituximab Reference Product in Subjects With Moderate to Severe Rheumatoid Arthritis | 135 |
| Juli 2025 | August 2025 | September 2025 | Oktober 2025 | November 2025 | Dezember 2025 | Januar 2026 | |
|---|---|---|---|---|---|---|---|
| A Randomized, Double‐Blind Study Comparing Pharmacokinetics and Pharmacodynamics of Proposed Biosimilar ABP 798 With Rituximab Reference Product in Subjects With Moderate to Severe Rheumatoid Arthritis | 8 | 0 | 5 | 23 | 4 | 3 | 6 |
| Zugriffe | |
|---|---|
| 2020_Burmester_etal.pdf | 134 |
